XML 90 R78.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidating Financial Information - Statement of Cash Flows (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash Flow from Operating Activities:    
Net cash provided by operating activities $ 217,067 $ 180,253
Cash Flow from Investing Activities:    
Proceeds from sale of assets held for sale 0 3,797
Insurance proceeds - damaged property 10,761 4,036
Proceeds from sale of property and equipment 304 1,717
Change in restricted investments (4,816) (1,490)
Capital expenditures (55,410) (107,064)
Net cash used in investing activities (49,161) (99,004)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 170,000 245,000
Payments on long-term debt (213,926) (134,000)
Payments on non-recourse debt (326,942) (7,490)
Proceeds from non-recourse debt 326,127 0
Taxes paid related to net share settlements of equity awards (4,177) (4,391)
Proceeds from issuance of common stock in connection with ESPP 252 264
Debt issuance costs (9,937) (990)
Proceeds from the exercise of stock options 1,077 1,372
Payment for repurchases of common stock 0 (70,446)
Dividends paid (116,122) (115,017)
Net cash used in financing activities (173,648) (85,698)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 824 (1,881)
Net Decrease in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (4,918) (6,330)
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 84,472 133,545
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period 79,554 127,215
The GEO Group, Inc.    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 130,455 118,354
Cash Flow from Investing Activities:    
Proceeds from sale of assets held for sale   0
Insurance proceeds - damaged property 0 0
Proceeds from sale of property and equipment 0 0
Change in restricted investments 0 0
Capital expenditures (12,002) (68,607)
Net cash used in investing activities (12,002) (68,607)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 170,000 245,000
Payments on long-term debt (213,926) (134,000)
Payments on non-recourse debt 0 0
Proceeds from non-recourse debt 0  
Taxes paid related to net share settlements of equity awards (4,177) (4,391)
Proceeds from issuance of common stock in connection with ESPP 252 264
Debt issuance costs (4,656) (990)
Proceeds from the exercise of stock options 1,077 1,372
Payment for repurchases of common stock   (70,446)
Dividends paid (116,122) (115,017)
Net cash used in financing activities (167,552) (78,208)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 0 0
Net Decrease in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (49,099) (28,461)
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 54,666 54,666
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period 5,567 26,205
Combined Subsidiary Guarantors    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 31,924 37,087
Cash Flow from Investing Activities:    
Proceeds from sale of assets held for sale   3,797
Insurance proceeds - damaged property 10,761 4,036
Proceeds from sale of property and equipment 112 0
Change in restricted investments (4,816) (1,490)
Capital expenditures (42,804) (36,998)
Net cash used in investing activities (36,747) (30,655)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 0 0
Payments on long-term debt 0 0
Payments on non-recourse debt 0 0
Proceeds from non-recourse debt 0  
Taxes paid related to net share settlements of equity awards 0 0
Proceeds from issuance of common stock in connection with ESPP 0 0
Debt issuance costs 0 0
Proceeds from the exercise of stock options 0 0
Payment for repurchases of common stock   0
Dividends paid 0 0
Net cash used in financing activities 0 0
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 0 0
Net Decrease in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (4,823) 6,432
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 4,823 4,952
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period 0 11,384
Combined Non-Guarantor Subsidiaries    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 54,688 24,812
Cash Flow from Investing Activities:    
Proceeds from sale of assets held for sale  
Insurance proceeds - damaged property 0 0
Proceeds from sale of property and equipment 192 1,717
Change in restricted investments 0 0
Capital expenditures (604) (1,459)
Net cash used in investing activities (412) 258
Cash Flow from Financing Activities:    
Proceeds from long-term debt 0 0
Payments on long-term debt 0 0
Payments on non-recourse debt (326,942) (7,490)
Proceeds from non-recourse debt 326,127  
Taxes paid related to net share settlements of equity awards 0 0
Proceeds from issuance of common stock in connection with ESPP 0 0
Debt issuance costs (5,281) 0
Proceeds from the exercise of stock options 0 0
Payment for repurchases of common stock   0
Dividends paid 0 0
Net cash used in financing activities (6,096) (7,490)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 824 (1,881)
Net Decrease in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 49,004 15,699
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 24,983 73,927
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period $ 73,987 $ 89,626